SCHEMBL2986998

SCHEMBL2986998

CC(C)CCNC(=O)c1csc(N)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PANK3 Q9H999 1/20 0.56
CNR1 P21554 1/20 0.48
ALDH1A1 P00352 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
HIF1A Q16665 1/20 0.43
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27995676 0.85 PANK3 (0.43) PANK3CNR1ALDH1A1NPC1RAB9A
SCHEMBL2986992 0.83 PANK3 (0.54) PANK3CNR1ALDH1A1NPC1RAB9A
SCHEMBL2236634 0.83 HIF1A (0.41) PANK3ALDH1A1NPC1RAB9AMEN1
SCHEMBL2236649 0.83 HIF1A (0.41) PANK3ALDH1A1NPC1RAB9AMEN1
SCHEMBL9331129 0.83 ALDH1A1 (0.47) CNR1ALDH1A1NPC1RAB9AMEN1
SCHEMBL6981525 0.82 ACHE (0.53) PANK3ALDH1A1NPC1RAB9AMEN1
SCHEMBL27995842 0.81 MAOB (0.46) ALDH1A1NPC1RAB9AMEN1MAPT
SCHEMBL26374347 0.80 HDAC3 (0.49) ALDH1A1NPC1RAB9AMEN1MAPT
SCHEMBL2642628 0.80 ALDH1A1 (0.55) CNR1ALDH1A1NPC1RAB9AMEN1
SCHEMBL2996975 0.79 USP2 (0.48) ALDH1A1NPC1RAB9AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190773-A1 Anti-Cytokine Heterocyclic Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-07-29 US disclosed
US-20060276496-A1 Anti-Cytokine Heterocyclic Compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276496-A1 Anti-Cytokine Heterocyclic Compounds MAPKAPK2, MAP4K2, MAP3K2 PANK3 423/4885CNR1 3515/4885ALDH1A1 3894/4885
US-20100190773-A1 Anti-Cytokine Heterocyclic Compounds MAPKAPK2, MAP4K2, MAP3K2 PANK3 423/4885CNR1 3515/4885ALDH1A1 3894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.